Anupam Rasayan India Ltd (NSE:ANURAS)
1,328.20
+34.30 (2.65%)
Jun 1, 2026, 3:29 PM IST
Anupam Rasayan India Revenue
In the fiscal year ending March 31, 2026, Anupam Rasayan India had annual revenue of 23.65B INR with 64.61% growth. Anupam Rasayan India had revenue of 6.36B in the quarter ending March 31, 2026, with 27.49% growth.
Revenue
23.65B
Revenue Growth
+64.61%
P/S Ratio
6.39
Revenue / Employee
9.08M
Employees
2,606
Market Cap
151.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 23.65B | 9.28B | 64.61% |
| Mar 31, 2025 | 14.37B | -380.95M | -2.58% |
| Mar 31, 2024 | 14.75B | -1.27B | -7.92% |
| Mar 31, 2023 | 16.02B | 5.28B | 49.19% |
| Mar 31, 2022 | 10.74B | 2.58B | 31.59% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BASF India | 149.44B |
| PCBL Chemical | 81.89B |
| Galaxy Surfactants | 52.48B |
| Gujarat Fluorochemicals | 50.38B |
| Jubilant Ingrevia | 43.88B |
| Gulf Oil Lubricants India | 41.54B |
| Fine Organic Industries | 23.66B |
| Acutaas Chemicals | 13.39B |
Anupam Rasayan India News
- 9 days ago - Anupam Rasayan India acquires up to 48.2% stake in Bliss GVS Pharma - Business Upturn
- 9 days ago - Anupam Rasayan India to acquire up to 48.2% stake in Bliss GVS Pharma - Business Upturn
- 9 days ago - Anupam Rasayan reports 65% revenue growth in FY26, driven by strategic expansions - Business Upturn
- 9 days ago - Anupam Rasayan announces resignation of Deputy CFO Vishal Thakkar - Business Upturn
- 9 days ago - Anupam Rasayan to acquire up to 74.20% stake in Bliss GVS Pharma for Rs 1,369 crore - Business Upturn
- 9 days ago - Anupam Rasayan to acquire 74.20% stake in Bliss GVS Pharma for Rs 1,369 crore - Business Upturn
- 6 months ago - Anupam Rasayan India Ltd At US Acquisition Update Call Transcript - GuruFocus
- 6 months ago - Anupam Rasayan signs definitive agreement to acquire U.S.-based Jayhawk Fine Chemicals Corporation - Business Upturn